Ernexa Therapeutics Inc (ERNA)

Mar 21, 2026

Eterna Therapeutics Faces Nasdaq Delisting Risk After Notice - The Globe and Mail

Mar 21, 2026

Mar 21, 2026

Ernexa Therapeutics Inc. Files Form 8-K: Notice of Nasdaq Delisting and Company Response – March 2026 - Minichart

Mar 21, 2026

Mar 21, 2026

Ernexa Therapeutics receives Nasdaq delisting notice due to minimum bid price By Investing.com - Investing.com India

Mar 21, 2026

Mar 20, 2026

Ernexa Therapeutics receives Nasdaq delisting notice due to minimum bid price - Investing.com Australia

Mar 20, 2026

Mar 20, 2026

Ernexa Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Mar 20, 2026

Mar 17, 2026

Resistance Check: Is PAVmed Inc stock a value trap2026 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

AI Stocks: Why is Ernexa Therapeutics Inc stock going upTrade Risk Report & High Conviction Buy Zone Alerts - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Ernexa Therapeutics Inc may offer up to $50 million of securitiesSEC filing - marketscreener.com

Mar 16, 2026

Mar 16, 2026

Ernexa Therapeutics IncMay Offer Up To $50 Million Of SecuritiesSEC Filing - TradingView

Mar 16, 2026

Mar 13, 2026

Ernexa Therapeutics Inc. 2025 Annual Report: Synthetic Allogeneic iMSC Therapy, Business Overview, Key Risks, and Patent Portfolio - Minichart

Mar 13, 2026

Mar 13, 2026

Ernexa Therapeutics 2025 10-K: $0.0M Revenue, Net Loss $(14.08)M - TradingView

Mar 13, 2026

Mar 13, 2026

Ernexa Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 13, 2026

Mar 12, 2026

Aug Wrap: Is Ernexa Therapeutics Inc exposed to currency risksPortfolio Growth Summary & Technical Analysis for Trade Confirmation - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

Ernexa Therapeutics Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 12, 2026

Mar 06, 2026

Aug Sentiment: What is Ernexa Therapeutics Incs book value per shareJuly 2025 Price Swings & Accurate Entry/Exit Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

Breakout Move: Is Ernexa Therapeutics Inc a strong candidate for buy and holdJuly 2025 Institutional & Pattern Based Trade Signal System - baoquankhu1.vn

Mar 05, 2026

Mar 04, 2026

Ernexa Therapeutics Inc.Common Stock (NQ: ERNA - FinancialContent

Mar 04, 2026

Mar 04, 2026

Comparing Aditxt (NASDAQ:ADTX) & Ernexa Therapeutics (NASDAQ:ERNA) - Defense World

Mar 04, 2026

Feb 27, 2026

ERNA Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026

Feb 27, 2026

Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosure - The Globe and Mail

Feb 27, 2026

Feb 26, 2026

Ernexa Therapeutics updates investor presentation, posts Exhibit 99.1 on website - TradingView

Feb 26, 2026

Feb 26, 2026

Ernexa Therapeutics (NASDAQ: ERNA) furnishes new February 2026 investor presentation - Stock Titan

Feb 26, 2026

Feb 24, 2026

Ernexa Therapeutics (NASDAQ:ERNA) Trading Down 11.4% – Time to Sell? - Defense World

Feb 24, 2026

Feb 20, 2026

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series - GlobeNewswire

Feb 20, 2026

Feb 20, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 20, 2026

Feb 20, 2026

Will Ernexa Therapeutics Inc. stock outperform value stocksQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru

Feb 20, 2026

Feb 18, 2026

Insider Stock Purchases: February 18, 2026 - Quiver Quantitative

Feb 18, 2026

Feb 17, 2026

Ernexa therapeutics ten percent owner Cherington buys $2m in stock By Investing.com - Investing.com India

Feb 17, 2026

Feb 17, 2026

Ernexa therapeutics ten percent owner Cherington buys $2m in stock - Investing.com

Feb 17, 2026

Feb 17, 2026

Ernexa Therapeutics 10% Owner Acquires 4 Million Shares - TradingView

Feb 17, 2026

Feb 16, 2026

ERNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 16, 2026

Feb 16, 2026

Will Ernexa Therapeutics Inc. outperform tech stocksJuly 2025 Chart Watch & Accurate Buy Signal Notifications - mfd.ru

Feb 16, 2026

Feb 16, 2026

Can Ernexa Therapeutics Inc. continue delivering strong returnsQuarterly Trade Review & Capital Efficiency Focused Strategies - mfd.ru

Feb 16, 2026

Feb 14, 2026

Will Ernexa Therapeutics Inc. stock remain a Wall Street favoriteWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru

Feb 14, 2026

Feb 12, 2026

Will Ernexa Therapeutics Inc. stock benefit from green energy trendsTrade Volume Summary & Accurate Buy Signal Notifications - mfd.ru

Feb 12, 2026

Feb 11, 2026

Eterna Therapeutics Completes Public Offering to Bolster Capital - TipRanks

Feb 11, 2026

Feb 11, 2026

Ernexa Therapeutics Signs Multiple Financing Agreements - TradingView

Feb 11, 2026

Feb 11, 2026

Profit Review: Can Ernexa Therapeutics Inc. be recession proofWeekly Gains Report & Daily Momentum Trading Reports - mfd.ru

Feb 11, 2026

Feb 11, 2026

What hedge fund activity signals for Ernexa Therapeutics Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - mfd.ru

Feb 11, 2026

Feb 08, 2026

Total debt of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView

Feb 08, 2026

Feb 06, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Feb 06, 2026

Feb 06, 2026

Ernexa Therapeutics prices $10.5 million public offering at $0.50 per share - Investing.com

Feb 06, 2026

Feb 06, 2026

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering - The Manila Times

Feb 06, 2026

Feb 06, 2026

Ernexa Therapeutics Inc. Announces Pricing of $10.5 Million Public Offering of Common Stock and Warrants - Quiver Quantitative

Feb 06, 2026

Feb 05, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Feb 05, 2026

Feb 05, 2026

Street Watch: Is Ernexa Therapeutics Inc forming bullish engulfing patternsQuarterly Investment Review & Reliable Entry Point Alerts - baoquankhu1.vn

Feb 05, 2026

Feb 04, 2026

Valuation Update: Why is Ernexa Therapeutics Inc stock going up2025 Volume Leaders & Proven Capital Preservation Methods - baoquankhu1.vn

Feb 04, 2026

Feb 03, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Feb 03, 2026

Feb 03, 2026

Ernexa Therapeutics Advances toward First-in-Human Trial for Ovarian Cancer Following Successful Pre-IND Meeting with FDA - Quiver Quantitative

Feb 03, 2026

Feb 03, 2026

Ernexa Therapeutics Participates in Virtual Investor “What - GlobeNewswire

Feb 03, 2026

Jan 27, 2026

Japanese trade program selects Ernexa Therapeutics among elite biotech group - Investing.com Canada

Jan 27, 2026

Jan 27, 2026

Ernexa Therapeutics Selected for Japan Entry Acceleration Program to Advance Innovative Cell Therapies - Quiver Quantitative

Jan 27, 2026

Jan 27, 2026

Ernexa Therapeutics Selected as One of Only Ten Global - GlobeNewswire

Jan 27, 2026

Jan 25, 2026

New Highs: Can Ernexa Therapeutics Inc be recession proofEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Jan 25, 2026

Jan 21, 2026

Can Ernexa Therapeutics Inc. be recession proofJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn

Jan 21, 2026

Jan 20, 2026

Top movers in Tuesday's after hours session - ChartMill

Jan 20, 2026

Jan 18, 2026

Breakout Zone: Is RICK showing insider buyingRisk Management & Growth Focused Investment Plans - baoquankhu1.vn

Jan 18, 2026

Jan 18, 2026

Update Report: Is Ernexa Therapeutics Inc forming bullish engulfing patternsEarnings Recap Summary & Long Hold Capital Preservation Plans - baoquankhu1.vn

Jan 18, 2026

Jan 17, 2026

Can Ernexa Therapeutics Inc continue delivering strong returnsPortfolio Gains Report & Reliable Intraday Trade Plans - baoquankhu1.vn

Jan 17, 2026